TSD Unveils 2026–2027 Medical Display Product Roadmap, Leading Precision Medical Visualization
Dual Product Lines for Surgical & Clinical Scenarios
TSD’s new medical display portfolio includes two core series to meet operating room, imaging reading, and daily clinical demands:
Flagship high‑end models for minimally invasive surgery, endoscopic imaging, and critical surgical visualization
Cost‑effective high‑brightness displays for clinics, wards, and routine diagnostic reading
Available sizes range from 23.8” to 32”, supporting wide compatibility with medical imaging equipment and workflow systems.
Flagship Surgical Displays: 4K, MiniLED & 3D Polarized Technology
- 3840×2160 UHD resolution
- Typical brightness: 800–850 cd/m²
- Contrast ratio: 1000:1 to 1500:1
- Professional interfaces: HDMI 2.0, DP 1.2, 12G‑SDI optional
- DICOM compliance, ΔE ≤ 1 color accuracy
- MiniLED backlight for enhanced contrast and local dimming
- Ultra‑fine detail reproduction for surgical scenes
- Under rapid development and scheduled for mass production in 2026
- 900 cd/m² typical brightness, 2000:1 contrast ratio
- Polarized 3D imaging for depth perception in minimally invasive surgery
- Dual 12G‑SDI input & output for real‑time surgical video
All surgical models feature true flat AR protective glass, optical bonding, IP65 front / IPX2 whole unit, OSD touch keys, PIP/PBP, and remote control via RJ45.
Clinical Displays: High Brightness & Touch‑Ready Design
TSD’s 23.8” / 27” FHD Clinical Displays deliver stable performance for daily diagnosis:
- 1920×1080 resolution
- Typical brightness: 600–1000 cd/m²
- 1000:1 contrast ratio, DICOM calibrated
- Optional PCAP touch, easy cleaning and disinfection
- Ideal for clinics, wards, and examination rooms
4K MiniLED Surgical Display Project Launched
TSD has started full development of its 4K MiniLED Surgical Display as of April 2026, with a cross‑functional R&D team covering mechanics, optics, electronics, software, testing, procurement, quality assurance, and project management.
The project follows a complete development flow:
- Target: Ready for mass production within 2026 and official launch in Q1 2027










